News Analysis
With most of the COVID-19 procurement attention focused on personal protective equipment (PPE), authorities and the pharmaceutical industry are closely monitoring another growing shortage—vital medicines.
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.


With most of the COVID-19 procurement attention focused on personal protective equipment (PPE), authorities and the pharmaceutical industry are closely monitoring another growing shortage—vital medicines.